Indivior Pharmaceuticals Inc
INDV
株式のランク
#3885
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
株価
$34.01
最終同期: 2026-10-19
時価総額
$4.24B
変化（1日）
4.81%
変化（1年）
40.02%
国
US
取引 Indivior Pharmaceuticals Inc (INDV)
カテゴリー
Healthcare
Indivior Pharmaceuticals Inc（INDV）の利益
Jun 2026 時点の利益 TTM: $393.00M
Indivior Pharmaceuticals Inc の最新の財務報告によると、同社の現在の利益は $393.00M です。2023 年には $-149.00M の利益を上げ、これは 2022 年の利益 $-89.00M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Indivior Pharmaceuticals Inc の利益の推移（2016 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $393.00M | 2,707.14% |
| 2024 | $14.00M | -109.40% |
| 2023 | $-149.00M | 67.42% |
| 2022 | $-89.00M | -146.84% |
| 2021 | $190.00M | -209.83% |
| 2020 | $-173.00M | -196.11% |
| 2019 | $180.00M | -32.21% |
| 2018 | $265.53M | 84.52% |
| 2017 | $143.91M | 60.35% |
| 2016 | $89.75M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 349.00% |
IN
|
